Igm Biosciences, INC.

Based in CA

🤖

AI Overview

With $2.0M in lobbying spend across 14 quarterly filings, Igm Biosciences, INC is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2021 to 2024.

$2.0M
Total Spend
4
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2021$140K
2022$660K
2023$930K
2024$250K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED

  • Issues relating to the development of antibody therapy for COVID-19
  • Issues relating to the development of antibody therapy for COVID-19.
  • Issues related to supply chain and biopharmaceutical manufacturing.
  • H.R.2471 - Consolidated Appropriations Act, 2022 COVID Supplemental Appropriation FY2023 Defense Appropriations S.2076/H.R.3932 - PASTEUR Act of 2021 S.3799 - PREVENT Pandemics Act Issues related to t
  • COVID Supplemental Appropriation FY2023 Defense Appropriations S.2076/H.R.3932 - PASTEUR Act of 2021 S.3799 - PREVENT Pandemics Act Issues related to the development of an antibody therapy for COVID-1

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.